Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Survivors of Hodgkin lymphoma (HL) have an increased risk of subsequent malignant neoplasms (SMNs). Response-adapted treatment may decrease this risk by reducing exposure to therapy associated with SMN risk. The Children’s Oncology Group study AHOD0031 evaluated response-adapted therapy for children...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Giulino-Roth, Lisa, Pei, Qinglin, Buxton, Allen, Bush, Rizvan, Wu, Yue, Wolden, Suzanne L., Constine, Louis S., Kelly, Kara M., Schwartz, Cindy L., Friedman, Debra L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2021
Konular:
Clinical Trials and Observations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7976513/
https://ncbi.nlm.nih.gov/pubmed/33512412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020007225
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller